Inflammatory bowel disease, including ulcerative colitis and Crohn's disease
Conditions
Interventions
Observation group:None
Sponsors
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients with a confirmed diagnosis of inflammatory bowel disease. 2.Moderate to severe active inflammatory bowel disease with poor response, intolerance, or contraindications to one or more anti-TNF-a agents. 3.Age >=18 years. 4.Patients voluntarily participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Concurrent infectious diseases, such as intestinal tuberculosis or infectious colitis. 2.Scheduled inflammatory bowel disease-related surgical treatment within 4 weeks. 3.Concomitant use of other biologic or small molecule agents during the treatment process. 4.Vulnerable populations, including individuals with mental illness, cognitive impairment, critically ill patients, pregnant women, and illiterate individuals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety; | — |
Countries
China
Contacts
Public ContactCao Qian
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Outcome results
None listed